inTrigue Case Study

This case study derives from a Volv engagement, which started in July 2017. A pharmaceutical company approached Volv Global to develop a prediction model to identify additional patients suffering from the rare disease treatable by its specialist medicine, using its rare event finding technology.

From this original engagement, the inTrigue methodology was born.